Mixtard 30 to be discontinued

NovoNordisk is discontinuing all presentations of Mixtard 30 at the end of the year, for commercial reasons. The Penfill cartridges, prefilled InnoLet injector and 10ml vials of the biphasic insulin - a mixture of 30% soluble and 70% isophane insulin - will all be withdrawn on 31 December.

Prescribers should ensure that patients are changed to an alternative insulin preparation before this date. When choosing an alternative insulin, prescribers should take into consideration the equivalent dose and type of insulin, suitability of the device and cost. The decision should be made on a case by case basis.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Don't prescribe analgesics for chronic pain, new NICE guidance advises

Don't prescribe analgesics for chronic pain, new NICE guidance advises

Draft NICE guidance on chronic pain warns that prescribing...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Stepping down of asthma treatment 'worryingly infrequent' despite clinical and cost benefits